Drugs / Recombinant LH
Recombinant LH
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT01500863 | Nov 2011 → May 2012 | ovarian hyperstimulation syndrome | IVI Madrid | Completed | No outcome recorded |
| Phase 4 | NCT01936077 | Jun 2010 → May 2013 | infertility disorder | Assuta Hospital Systems | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01457703 | Jun 2010 → Jul 2013 | obesity disorder | University of Colorado, Denver | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06883890 Comparator | Mar → Nov 2025 overdue | ovarian disorder | University Hospital of Modena | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07121751 Comparator | Sep 2025 → Aug 2026 overdue | infertility disorder | Dunamenti REK Istenhegyi IVF Center | Not yet recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02244866 Comparator | Oct 2012 → Apr 2014 | infertility disorder | Vietnam National University | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant LH | “150 IU of recombinant FSH and 75 IU of recombinant LH (Pergoveris) daily subcutaneous injection” NCT02244866 ↗ |
| Known as | Luveris | “Drug: Recombinant LH (Luveris)” NCT06883890 ↗ |
| Known as | rLH | “In the treatment group patients will receive the pretreatment with rLH, a daily dose of 187.5 IU (75 U in the morning and 112.5U in the evening) rLH treatment for 60 days will...” NCT06883890 ↗ |
| Action | Activate | “Used to stimulate ovarian function in women.” NCT01457703 ↗ |
| Modality | Protein / enzyme biologic | “recombinant luteinizing hormone” PMID 25740882 ↗ Mar 2015 |
| Route | Subcutaneous | “150 IU of recombinant FSH and 75 IU of recombinant LH (Pergoveris) daily subcutaneous injection” NCT02244866 ↗ |